Mesenchymal stromal cell-derived extracellular vesicles (MSC-EVs) have emerged as promising cell-free therapeutics that recapitulate key paracrine functions of MSCs whilst mitigating limitations of viable-cell therapies. Clinical translation is hindered by inconsistent dose metrics, lack of validated potency assays, and manufacturing complexities. Here we review advances in MSC-EV standardisation, source and culture determinants, engineering and delivery platforms, and clinical applications, exemplified by chronic wound healing. We operationalise dual-metric dosing (particles plus protein) linked to mechanism-aligned potency assays, adopt a route-aware exposure–response framework to guide delivery strategies, and propose decision matrices aligning MSC sources and bioprocesses with indication-specific tasks. Good Laboratory Practice safety panels and Good Manufacturing Practice scale-up strategies are outlined to support regulatory readiness. Early clinical studies demonstrate feasibility and short-term safety but reveal heterogeneous efficacy, underscoring the need for harmonised dosing and potency measures. Collectively, these insights provide a roadmap to advance MSC-EVs as indication-matched regenerative medicines.
Pectus excavatum is a characteristic thoracic deformity of Marfan syndrome (MFS) that plastic surgeons often encounter during initial evaluation. Herein, we have described the case of a 2-year-old boy who presented with pectus excavatum. However, the initial assessment did not adequately explore the physical features or family history suggestive of MFS. At the 3-year health checkup, the patient was observed to have long fingers, leading to a referral to pediatrics. Genetic testing revealed that the patient, his sister, and father had a fibrillin-1 (FBN1) mutation. Multidisciplinary management was initiated for the children, and early detection of asymptomatic dilation of the sinus of Valsalva in the father led to preventive aortic root replacement (remodeling procedure). This case illustrates that plastic surgery can serve as an entry point for MFS detection, and insufficient evaluation risks missing life-threatening complications.
Long-standing blepharoptosis following trauma remains incompletely characterised. We report a 57-year-old man with unilateral blepharoptosis of 40 years' duration, with patient-reported immediate onset after blunt periorbital trauma and more recent worsening. The temporal association supports a traumatic contribution, although superimposed involutional aponeurotic change cannot be excluded. Preoperative margin reflex distance 1 (MRD1) and clinical levator function (LF; upper-eyelid excursion) of the affected eyelid were -0.5 mm and 2.0 mm, respectively. Intraoperatively, broad detachment of the levator aponeurosis was identified. After adhesiolysis and lateral horn release, attempted upgaze elicited visible posterior retraction and transmitted tension within the exposed levator-aponeurosis complex; these qualitative findings supported the decision to perform external levator aponeurosis advancement. At 3 years, MRD1 and LF were 2.7 mm and 12.0 mm, respectively. In this patient, very low preoperative clinical LF did not preclude durable improvement in upper-eyelid excursion after release of restriction and levator aponeurosis advancement.